What is the current stock price of Bioceltix S.A. (BCX.WA)?

As of the latest market data, Bioceltix S.A. (BCX.WA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Bioceltix S.A. (BCX.WA) pay a dividend?

Based on current data, Bioceltix S.A. does not have a confirmed active dividend policy.

What is the market cap of Bioceltix S.A.?

The current market capitalization of Bioceltix S.A. (BCX.WA) is approximately unavailable.

BCX.WA

Bioceltix S.A.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-11-08

Beta

1.03

Websitebioceltix.com↗